All participants in the Phase 3 clinical trial of Taiwan-based Medigen Vaccine Biologics Corp.'s COVID-19 vaccine in Paraguay have now received two shots of either the Medigen or AstraZeneca vaccine, the company said Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan headline news
09/30/2026 10:14 AM - Business
U.S. dollar up in Taipei trading
09/30/2026 10:12 AM - Business
Taiwan shares open higher
09/30/2026 09:09 AM - Business
Amazon taking part in Taiwan PCB maker's private placement
09/29/2026 09:06 PM - Sports
Taiwan snatches 2 more silvers in shooting, Kurash at Asian Games
09/29/2026 08:42 PM